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Introduction
Type 1 diabetes (T1D) is an autoimmune disease that occurs when T lymphocyte
cells attack and destroy beta cells in the pancreas.1 The cause of T1D is considered to be
a combination of genetic predisposition and environmental or lifestyle risk factors.
Destruction of the pancreatic islet beta cells, which secrete insulin, leads to complete
dependency on exogenous insulin to maintain glucose homeostasis. Insulin is a hormone
that stimulates glucose uptake as well as lipid synthesis and is important for maintaining
blood glucose levels.1 In most cases of T1D, people have inherited risk factors from both
parents. The most important genes implicated with susceptibility to T1D are the human
leukocyte antigen (HLA) complex on chromosome 6.2 Most young children with T1D
carry either or both susceptibility haplotypes in the HLA class II region (90-95%).2 In the
United States, individuals with a first-degree relative with T1D have a 1 in 20 lifetime
risk of developing T1D, compared to a 1 in 300 lifetime risk for the general population.3
Caucasians have the highest rate of T1D, therefore, it is possible that these inherited risk
factors are more common in Caucasians.4 Maahs et al. (2010) conclude that the rates of
T1D in non-Hispanic white youth are among the highest in the world (prevalence of T1D
was 2.0/1,000 and the incidence was 23.6/100,000).2 In 2002-2003, children with T1D
(n=1905) were diagnosed in the SEARCH for Diabetes in Youth study (SEARCH) from
a population of more than 10 million.2 Rates were highest in non-Hispanic white youth
as compared to other races/ethnicities and were slightly higher in females as compared to
males (RR 1.028; 95% CI 1.025-1.030).2 The EURODIAB ACE study group looked at
the variation and trends in incidence of childhood diabetes in Europe between 1989 and
1994.2 This study group found that the annual increase in the incidence rate of T1D was
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3.4% (95% CI 2.5-4.4%).2 The rates of increase were found to be highest in the youngest
age group: ages 0-4 years 6.3% (95% CI 1.5-8.5%), 5-9 years 3.1% (95% CI 1.5-4.8%),
and 10-14 years 2.4% (95% CI 1.0-3.8%).2 However, since an environmental trigger is
also involved in the development of the disease when an individual has already inherited
a predisposition to diabetes, it may take years for T1D to develop in an individual with a
predisposition.4 In studies following relatives of people with T1D, researchers found that
those who developed T1D later in life had certain autoantibodies in their blood for years
prior to the development of the disease.4 Four autoantibodies are markers of beta cell
autoimmunity in type 1 diabetes: islet cell cytoplasmic autoantibodies (ICA), insulin
autoantibodies (IAA), antibodies to the 65-kDa isoform of glutamic acid decarboxylase
(GADA), and antibodies to the protein tyrosine phosphate-related IA-2 molecule (IA2A).5 Autoantibodies against GAD 65 are found in 80% of persons with type 1 diabetes.6
Presence of ICA and IA-2A at diagnosis for type 1 diabetes range from about 69-90%
and 54-75%.6 Insulin autoantibodies are usually the first marker in young children at risk
for diabetes and found in approximately 70% of young children at time of diagnosis.6
The more antibodies present in an individual, the greater the risk of developing type 1
diabetes.6
Many people at risk for type 1 diabetes do not develop it. Researchers have
examined associations between various environmental triggers and development of the
disease. Cold climate, viruses, intestinal microbiota, infant diet, birth weight, and infant
weight gain are environmental factors thought to play a role in the risk of developing
T1D.4 One trigger may be related to cold weather; more cases of T1D develop in the
winter and more cases are seen in areas with cold climates.7 According to Waernbaum
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and Dahlquist (2016), there is an association with incidence of type 1 diabetes in children
and low mean temperature independent of a possible effect of sunshine hours after
adjustment for age, sex, and time trend.8 Some researchers suggest viruses that have mild
effects on some individuals could trigger T1D in others.7 Enteroviral infection, in
particular Coxsackie B4, showed an accelerated prediabetes progression in diabetesprone NOD mice.5 Early introduction of diet is thought to play a role in the development
of T1D as it is less common in people who were breastfed and who were introduced to
solid foods at later ages. The protection that breastfeeding can offer against the
development of childhood obesity and T1D in children at risk for T1D is unknown and
may be related to many different factors. The purpose of this project is to review the
literature on the association between infant diet, including breastfeeding and
complementary foods, and the development of obesity and T1D. This information will
be used to prepare a secondary analysis proposal to examine the association between
length of exclusive breastfeeding and obesity risk in children at risk for T1D for
submission to the Presentations and Publications Committee of the Trial to Reduce
IDDM in the Genetically at Risk (TRIGR) study.

Specific Aim 1: To describe the association between length of exclusive breastfeeding
and obesity in children at risk for T1D
Hypothesis 1: Shorter duration of exclusive breastfeeding predisposes children to
obesity
Null Hypothesis 1: There will be no difference in obesity risk by length of
exclusive breastfeeding

3

Specific Aim 2: To determine the association between length of exclusive breastfeeding
and the development of obesity in children at risk for T1D is modified by maternal T1D
status
Hypothesis 2: Risk of obesity will be higher in children who have a mother with
T1D
Null Hypothesis 2: There will be no difference in obesity risk by maternal T1D
status

Literature Review
Nutrition and Type 1 Diabetes
Breastfeeding and Infant Formula
Breastfeeding has several benefits for infants. There are three phases in breast
milk production: colostrum (day 1 to 5 postpartum), transitional milk (day 6 to 15
postpartum), and mature milk (after day 15 postpartum).9 Colostrum contains substances
that offer general benefits, such as growth factors involved in the growth and
development of cells in the digestive tract and transfer factors that may have general
immune-activating properties.10 In addition to immunoglobulins, colostrum contains
neutrophils and macrophages, which secrete a range of immune-related components
including cytokines and antimicrobial proteins and peptides, such as lysozyme,
lactoferrin, and proline-rich polypeptides.10 Phospholipids in human milk are an
important source of energy for infants and are also providers of long-chain
polyunsaturated fatty acids, which play an important role in the growth and brain
development of neonates.11 Fatty acids of high nutritional relevance such as arachidonic
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acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) found in
human milk are involved in child growth, visual acuity, and neurological development.11
The World Health Organization (WHO) recommends exclusive breastfeeding up to six
months of age.12 Previous research has suggested that breast feeding for shorter than
three months and early exposure to cow’s milk proteins (such as bovine serum albumin)
can trigger diabetes.13 Some retrospective studies have shown a small reduction in the
risk for T1D with breastfeeding; however, all but one of the prospective birth cohort
studies failed to find a protective effect.7
These findings suggest that breastfeeding may play a protective role in the
relationship between dietary factors and T1D.7 Butalia et al. (2016) discusses a casecontrol study by Borch-Johnsen (1984) demonstrating that children with T1D were
breastfed for shorter durations than their healthy siblings and general population.14 Those
who were exclusively breastfed for longer than 2 weeks were at decreased risk for
developing T1D, but the protection was attenuated for those exclusively breastfed for
more than 3 months.14 It is possible that products with cow’s milk-based protein may
increase the risk for advanced beta-cell autoimmunity, whereas breastfeeding may be
protective because breast milk has several antimicrobial and anti-inflammatory
properties.14 One possible mechanism is that early introduction of cow’s milk protein
may induce mucosal inflammation and increased gut permeability.14 This increases the
permeability of food antigens through the intestine, which leads to the stimulation of
autoimmune processes, pancreatic islet inflammation, and destruction of beta cells.14
While breastfeeding may play a protective role in the risk for developing T1D, it
is also important to look at other diet influences. In a double-blind, randomized trial
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(TRIGR Pilot II) 230 infants genetically at risk for T1D were randomly assigned either
the intervention formula (extensively hydrolyzed casein-based formula) or the control
formula (80% intact milk protein and 20% hydrolyzed milk protein) whenever breast
milk was not available.7 At least one autoantibody developed in 17 of the children in the
casein hydrolysate group (17%) and 33 in the control group (30%).7 However, the larger
phase three of the TRIGR study could not confirm this same effect on islet autoimmunity,
and follow up of the study participants for T1D continues.7 A higher cow’s milk intake
in children with islet autoimmunity might lead to T1D; however, the effect could be
mediated by certain fatty acids present in cow’s milk.7 If this were confirmed, further
dietary interventions to examine the preventive effect of diet on the development of On
T1D could be conducted.
One recent paper published reported breastfeeding, other milk feeding, and
complementary feeding patterns among infants in the TRIGR study. The large
population (n=2159) consisting of participants from 15 different countries provides an
assessment of infant feeding patterns in different regions of the world in mothers with
and without T1D.15 This paper documented that mothers with T1D breastfeed less than
those unaffected by the disease.15 During the first 3 days of life, the proportion of
exclusively breastfed infants of mothers with T1D ranged from 81% in Northern Europe
to 32% in Australia, but 94% of Australian mothers without T1D exclusively breastfed
their infants during the first 3 days of life.15 Sorkio et al. (2010) found that most (90%)
of the infants of mothers with and without T1D were initially breastfed, but breastfeeding
rates declined more among mothers with (50%) than without (72%) T1D at 6 months.16
The feeding pattern data from the TRIGR study will allow for evaluation of how infant
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diet is related to the development of autoimmunity and then progression to T1D by region
at the completion of the study in 2017.15

Complementary Foods
The American Academy of Pediatrics recommends waiting until 6 months of age
to start introducing solid foods, and to continue breastfeeding in combination with
complementary foods until 12 months of age if possible.17 Several studies have looked at
the association between introduction of solid foods and risk for T1D. Children initially
exposed to cereals between ages 0 and 3 months and those who were exposed at 7 months
of age or older had increased hazard of islet autoimmunity (4.32; 95% CI 2.0-9.35 and
5.36; 95% CI 2.08-13.8; respectively) compared with those who were first exposed
during the fourth through sixth month of life after adjustment for HLA genotype, family
history of T1D, ethnicity, and maternal age.18 The Finnish Diabetes Prediction and
Prevention (DIPP) study reported that early introduction (by 4 months of age) of root
vegetables increased the risk (1.75; 95% CI 1.11-2.75) of islet autoimmunity compared
with a later introduction of root vegetables.19 Researchers also reported that first
exposure to egg before eight months of age was associated with an increased risk of islet
autoimmunity.14 All Babies in Southeast Sweden (ABIS) showed that less than daily
consumption of vegetables (3-5 times per week) in the mother’s diet was associated with
increased risk (1.17; 95% CI 1.24-2.35) of islet autoimmunity.14 It is important to
interpret these study results with caution because there is a risk of false positive
associations caused by multiple comparisons. There are some inconsistencies with the
findings, but these studies support the idea that general antigenic stimulation is more
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important than the actual antigen in this disease process.14 In other words, the timing of
introduction of certain solid foods could be more important than the type of food
introduced. This could be due to immature immune response and the gut.
Introducing solid foods too soon may be a risk factor for developing islet
autoimmunity due to immature immune response to foreign antigens and a more
permeable gut in infants.20 Abnormalities in gut permeability have been linked to the
development of T1D.20 In a multinational cohort study of children at increased genetic
risk of T1D, a reduction in the risk of islet autoimmunity was observed in children that
received probiotics via dietary supplements and/or via fortified infant formula before or
at the age of 27 days compared with those who first received probiotics after 27 days or
not at all.20 Early probiotic exposure was associated with a 60% decrease in the risk of
islet autoimmunity among children with the DR3/4 genotype but not among other
genotypes.20 While studies have shown that breastfeeding for at least six months may
help reduce the risk of T1D, breastfeeding is not possible for some mothers for a variety
of factors.20 If mothers must use a formula, it appears that selecting a formula fortified
with probiotics may be beneficial in helping reduce the risk of T1D in children
genetically at risk.20 More research should be conducted to determine the effect of
supplemental probiotics on the development of autoimmunity and T1D in breastfed
infants who are genetically at risk.

Micronutrients
Previous research has provided some evidence to support a potential role of
vitamin D in the pathogenesis of T1D, and the factor believed to play a role is vitamin D
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receptor (VDR).14 The VDR gene is found in most tissues of the body, including the
immune system.14 The VDR gene is located on chromosome 12 and has a few allelic
variants. Some of these variations of the gene have been associated with an increased
risk for T1D.14 Countries at northern latitudes where sunlight exposure is lower and
vitamin D deficiency is more common have a higher incidence of T1D.14 Several studies
have reported lower levels of serum 25-OH vitamin D among patients with T1D
compared with healthy controls.14 The Endocrine Society Practice Guidelines on Vitamin
D define vitamin D deficiency as 25(OH)D <20 nanograms/mL, insufficiency as 21-29
nanograms/mL, and sufficiency as >30 nanograms/mL.21 On the contrary, a cohort study
of maternal intake of vitamin D was not found to be protective in offspring developing
T1D and beta-cell antibodies.14 Virtanen and Knip (2003) reviewed the results of a few
studies that evaluated vitamin D supplementation in infancy.22 Vitamin D
supplementation during infancy was inversely associated with the risk of T1D in a
European case-control comparison, whereas vitamin D or cod liver oil use during infancy
was not related to the risk of diabetes in a small Norwegian case-control series.22 Due to
contrary findings regarding vitamin D and the development of islet autoimmunity or
T1D, further research is needed on this topic.
There is little research on other micronutrients associated with T1D. It is possible
that vitamin E could play a role in preventing the development of T1D through its
function as an important free radical scavenger as well as through its inhibition of Nnitroso compound formation in food and in the human organism.22 In a Finnish casecontrol study within an adult cohort, an inverse relation was found between serum
concentrations of alpha-tocopherol at baseline and the development of T1D 4-14 years
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later; this association was independent of serum cholesterol levels and body mass index.22
Serum selenium or retinol concentrations were not related to the risk of T1D in that same
study.22 An Australian case-control study reported that vitamin C supplementation was
inversely related to the risk of T1D.22 Zinc concentrations in drinking water were also
observed to be inversely related to the risk of T1D in a Swedish case-control study.22
Virtanen et al. (1994) found that maternal nitrite intake was positively associated with the
risk of diabetes independent of the child’s own intake and when adjusted for several
sociodemographic factors.23 Norwegian case-control findings of an inverse association
between maternal cod liver oil supplementation during pregnancy and the risk of T1D in
the offspring suggest that either vitamin D, vitamin A, or n-3 fatty acids (which are all
abundant in cod liver oil) play a role in the development of T1D.22 Some of the
randomized placebo-controlled trials in subjects with recently diagnosed T1D suggest
that nicotinamide delays the decay of β cell function, whereas other studies found no
effect of nicotinamide.22 Further research is needed on various micronutrients associated
with the development of T1D.

Obesity and Risk of Type 1 Diabetes
An article by Nucci et al. (2012) aimed to evaluate the relationship between early
growth and regional variations in T1D incidence in children with familial and genetic risk
for T1D.24 They obtained anthropometric indices between birth and 5 years of age in
2160 children participating in the TRIGR study among different regions.24 They found
that children in Northern Europe had the highest weight z-score between birth to 12
months of age, while those in Southern Europe and USA had the lowest weight and
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length for height z-scores.24 The study concluded that there are regional differences in
early childhood growth that are consistent with the higher incidence of T1D in Northern
Europe and Canada compared to Southern Europe.24 This study allows for further
evaluation of the association between growth (obesity) and progression to T1D.24
Kibirige et al. (2003) looked at the relationship between body mass index and age
at diagnosis of T1D.25 The relationship between fatness and age at diagnosis was
examined in context of birth weight, weight change since birth, weight at diagnosis, BMI
at diagnosis, and BMI 12 months later in 94 children aged 1–16 years (49 boys and 45
girls) presenting for management of acute-onset T1D.25 The boys in this study were
found to have a greater BMI than the girls, and they were presented with diabetes at a
younger age.25
Birthweight and prevalence of overweight children have gradually increased in
Sweden over recent decades, and this trend seems to parallel with increasing incidence of
T1D occurring in childhood.26 Dahlquist et al. (2005) observed in a population-based
register study that the paralleling trend between increasing birthweight/overweight and
increasing incidence of childhood T1D is seen in the younger age-at-onset groups, but not
in the age groups older than 15 years at diagnosis.26 One explanation could be that the
overload of the beta cells due to increased insulin demand in the growing children may
accelerate the process of beta-cell destruction and lead to an earlier onset on T1D.26 This
study concluded that high birthweight as a risk factor for T1D may be limited to youngonset cases.26 The increase in T1D incidence in Sweden is seen in age groups younger
than 10, but not in young adults, which could be explained by the increasing
birthweight.26
11

Ljungkrantz et al. (2008) examined children’s height and weight gain from birth
to the time of diagnosis of T1D.27 Growth charts from 316 children 0-16 years old up to
the time of T1D diagnosis were compared with growth charts from age and gender
matched controls.27 Compared with controls in the year of diagnosis, children who
developed T1D were taller (0.5 vs. 0.36 SDS) and heavier (0.7 vs. 0.45 SDS).27 Children
who developed diabetes at 5 years old or less gained more in weight than in height during
the period between their third month and third year of life.27 Children who were
diagnosed between 6 and 10 years of age gained more in height before they were 5 years
old.27 The analysis from the study showed that a high weight or high BMI at 5 years old
indicated, more than other measurements, a high risk (OR 1.6; 95% CI 1.02-2.38) for
diabetes later during childhood, while height and weight at ages less than 5 years did not
add any further information on diabetes risk.27
In conclusion, breastfeeding is thought to help reduce the risk of developing T1D
in children genetically at risk. This could be due to a number of mechanisms including
the hormones in breast milk, the delay in introduction of complementary foods containing
foreign antigens that affect the islet autoimmunity with longer periods of breastfeeding,
or the protective effect that breastfeeding has against overweight/obesity in children.

Breastfeeding and Obesity
Many studies have reported that children who are breastfed are more likely to
maintain a healthy weight throughout childhood. The World Health Organization
(WHO) and United States Department of Health and Human Services have concluded
that breastfeeding for at least six months can help reduce the risk of obesity later in life.28

12

Human milk may be involved in growth and appetite control in the neonatal period and
infancy, affecting the programming of energy balance regulation in both childhood and
adulthood.28
A review article by Marseglia et al. (2015) provides a summary of what is known
about the possible relationship between breastfeeding and risk of obesity in childhood.28
Findings from different studies are discussed and possible mechanisms to explain the
association between breastfeeding and obesity are mentioned. Human milk varies from
day to day in composition, which influences metabolic state and diet of infant; it has been
shown that a dose- and time-dependent association could correlate with a lower BMI in
older children.28 This paper also states prolonged duration and exclusivity of
breastfeeding lead to lower growth rates during the first year of life and seem to lower
risks of overweight and obesity in preschool aged children.28 However, the data are
controversial with regard to the effect that breastfeeding early in life has on short- and
long-term obesity.28 The results are from observational studies, which can be affected by
many other confounding factors such as genetics, family structure, physical activity later
in life, and future eating patterns.
A 2007 meta-analysis conducted for the WHO showed that breastfeeding was
associated with a 22% reduced risk of obesity later in life.28 In a 2013 study, researchers
observed that exclusive breastfeeding for six to seven months of age was associated with
decreased risk of overweight and obesity compared with formula feeding after adjusting
for maternal factors (educational attainment, smoking status, and working status) and
child factors (gender, television viewing time, and computer game playing time).28
However, a cohort study of 8327 children from Hong Kong China did not find any
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association between breastfeeding and BMI at seven years of age.28 Not all authors agree
on the relationship between breastfeeding and overweight, so there is still the need for
further studies to clarify the association between the two.
The duration of breastfeeding can directly influence the infant’s ability to selfregulate milk intake and the infant’s growth. As a result, there are differences between
growth parameters in infants who are breastfed for a short vs. long time period.28 A
meta-analysis about the duration of breastfeeding and obesity, using formula fed infants
as the referent, noted that duration of breastfeeding and overweight were inversely
correlated.28 A shorter duration of breastfeeding is probably associated with an earlier
introduction of solid food, which contains more protein than breast milk.28 Shorter
duration of breastfeeding was correlated with reduced appetite signaling which induces a
greater number of feeding times. Recent studies have identified the role of the fat massand obesity-associated (FTO) gene in increasing BMI and adiposity. Abarin et al. (2012)
hypothesized that the longer duration of breastfeeding, through its ability to interfere on
the FTO gene, might reduce the risk of overweight later in life.28 In 18 studies, duration
of breastfeeding, if greater than 40 weeks, was positively related with a lower weight gain
at one year.28
Several hormone molecules seem to be involved in the development of obesity in
humans. Insulin, insulin-like growth factor I (IGF-1), leptin, adiponectin, ghrelin,
obestatin, and resistin are hormone molecules involved in the development of obesity.28
These hormones influence fat and lean body mass in healthy term infants and enhance
appetite signaling, which promotes child satiety-responsiveness and decreases risk of
over-eating.28 Leptin promotes fetus growth, has a positive effect on satiety, increases
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basal metabolism, and correlates with weight gain in newborns.28 Leptin is synthesized
and secreted in breast milk; it has been reported that higher serum leptin levels are found
during the first month of life in breast-fed infants than in formula fed infants.28
Adiponectin is released in breast milk. Adiponectin levels in newborns are directly
associated with birth weight and length, insulin sensitivity, and levels of leptin, and
inversely related with fat deposits and weight gain.28 Ghrelin is present in human milk
during lactation.28 Ghrelin is directly associated with birth weight, birth length, and age;
ghrelin is inversely related with weight gain in breastfed newborns of at least four
months, but not in formula fed infants.28 Obestatin is a hormone derived from the same
gene that codes for ghrelin. Obestatin is synthesized by ductal epithelium of mammary
gland or directly released from serum into breast milk and has been detected in colostrum
and mature milk.28 Obestatin is associated with less overfeeding, especially in the early
stages of breastfeeding.28 Although further studies are needed to clarify other factors
associated with breastfeeding and weight gain, these findings do suggest that breast milk
can play a critical role in metabolic development of newborns.
A study by Hunsberger (2014) aimed to show the association between
breastfeeding and overweight children when considering family structure.29 The
researchers suggested that breastfeeding alone does not protect children from being
overweight, but that other lifestyle and social factors play a role along with mothers who
chose to breastfeed. The WHO recommends children be exclusively breastfed for at least
six months because of other known benefits. The group that published this paper
reviewed the exposure to exclusive breastfeeding and overweight in the “Identification
and prevention of Dietary- and lifestyle-induced health EFfects In Children and infantS
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(IDEFICS)” study.29 IDEFICS was a multi-center European study that involved eight
different countries.29 Only children who could be defined as being exclusively breastfed
were included in the surveys for this study.29 Exclusive breastfeeding and
overweight/obesity combined were examined with adjustment for survey country, child
age, sex and birth weight, household income, maternal education, maternal
overweight/obesity, single or dual parent family structure, presence of one or more
foreign born parents, and tobacco use during pregnancy.29 In the fully adjusted model,
breastfeeding exclusively for four to six months was protective for overweight/obesity
when compared to children who were never exclusively breastfed.29 Also, exclusive
breastfeeding for six months showed more protection than four and five months
combined.29 When the role of family structure was investigated, being an only child was
not protective for children becoming overweight/obese.29 Although exclusive
breastfeeding for four to six months can be protective for overweight/obesity, it is
important to keep in mind that exclusive breastfeeding alone will not guarantee that
children will not become overweight or obese due to other environmental factors such as
family structure.29
A review by Spatz (2014) discussed the mechanism for how breastfeeding can
influence future eating habits.30 Infants learn about food and flavoring through both
amniotic fluid and breastfeeding.30 Human milk is influenced by maternal diet; when an
infant breastfeeds, the palate is exposed to new tastes.30 These early exposures to various
tastes have an influence on flavor preferences of children that may later affect food
choices.30 Research conducted on Dutch children found that children at seven years of
age who were breastfed for more than 16 weeks had a greater intake of fruits and
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vegetables compared to those children who had never been breastfed.30 The children who
had been breastfed were also less likely to consume white bread, soft drinks, chocolate
bars, and fried food.30 These findings provide evidence that breastfeeding can be
protective against children being overweight/obese due to the effects breastfeeding can
have on future food choices in children.

Methodology
Study Population
The TRIGR study is an international T1D prevention trial designed to determine
whether weaning to a hydrolyzed infant formula reduces the incidence of T1D in children
with a first- degree relative with the disease and increased HLA-defined genetic risk.5
Mothers with T1D diabetes were identified during pregnancy through endocrinologists or
high-risk pregnancy services.5 Fathers with T1D were identified by available history or
data already in the medical record of the pregnant women, interviewing women at
prenatal maternity clinic visits, and existing registries of T1D in some centers.5 The
newborn infants with a first-degree relative with T1D also had to fit the inclusion and
exclusion criteria to be recruited. The inclusion criteria included: the biological parent
and/or full (not half) sibling of the newborn infant had T1D as defined by the WHO; the
infant’s parents or legal guardians gave signed consent to participate; and the infant had
one of four different genotypes listed in the study [HLA-DQB1*02/0302;
HLA-DQB1*0302/x (x

DQB1*02, *0301, *0602); HLA-DQA1*05 -DQB1*02/y (y

DQA1*0201 -DQB1*02, DQB1*0302, *0301, *0602, *0603); HLA-DQA1*03 DQB1*02/y (y

DQA1*0201 -DQB1*02, DQB1*0302, *0301, *0602, *0603)].5 The
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newborn infants could not be recruited if they met any of the exclusion criteria.
Exclusion criteria for the study included: having an older sibling who had already been
included in the TRIGR intervention; multiple gestation; parents were unwilling or unable
to feed the infant cow milk (CM)-based products for any reason; the newborn infant had
a recognizable severe illness; the gestational age of the newborn infant was less than 35
weeks; inability of the family to take part in the study (the family had no access to any of
the study centers or the family had no telephone); the infant had received any infant
formula other than Nutramigen prior to randomization; the infant was older than 7 days at
randomization; and no HLA sample had been drawn before the age of 8 days.5
Recruitment for the study was carried out over the course of 4 years in 6 major
centers in the USA, in 18 centers in Canada, in 51 centers in 12 European countries, and
3 centers in New South Wales, Australia. In order to facilitate recruitment and minimize
any possible unintentional exposure to CM protein, attempts to identify and randomize
eligible families were made before the child was born.5
Using data from the Childhood Diabetes in Finland (DiMe) Study Group, the
German BABYDIAB study, and the DAISY study, a projected sample size of 2032
infants to be randomized for the trial was determined.5 To achieve this number, the
TRIGR study group determined that 4516 infants had to be screened assuming a
frequency of 45% of the genotypes conferring increased risk.5 Screening for TRIGR
began on 1 May 2002 and the target enrollment was achieved by 1 September 2006.5 A
paper published on the recruitment and retention of the TRIGR study by Franciscus et al.
(2013) stated that 5606 mothers registered worldwide, and 5000 of their infants were
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randomized.31 Of these, 2159 were HLA eligible and enrolled in the 8-month
intervention and 10-year follow up phases of the study.31

Anthropometrics
The weight and length or height of subjects were recorded at the time of
randomization (baseline). Anthropometrics were subsequently measured at the 3 month
visit, 6 month visit, 9 month visit, 12 month visit, 18 month visit, 2 year visit, and at each
annual visit thereafter until the maximum age of 14 years.5

Nutrition Assessment
In the TRIGR Study, the diet of the child and the compliance with avoiding intact
CM proteins were assessed by interview at the delivery hospital.5 The interview was
conducted via telephone with parents/guardians when the infant was 2 weeks of age and
1, 2, 4 and 5 months old.5 The interview was also conducted in person at the 3- and 6month visits.5 If the infant continued in the intervention after 6 months of age, telephone
interviews were also done at 7 and 8 months old.5 The dietary assessment was done via a
structured form, including information on the duration of total and exclusive
breastfeeding, the age at introduction, the duration of the study formula feeding, and the
amount of study formula given per feeding.5 The families were also asked about intake
of allowed foods and non-recommended foods and food groups.5 Measuring CM protein
antibody levels from sera at 3 months and 6 months also assessed compliance with the
avoidance of intact CM proteins.5
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The dietary interview form given at the two-week follow-up call included two
questions about what the baby had consumed at all during the first 3 days, and also what
the baby consumed primarily in the first 3 days (Appendix A). Then, a few questions
were asked about breastmilk consumption and study formula consumption; the subjects
were asked if they needed more study formula and how much of the study formula they
had at home at the time of 2 weeks. At 2 weeks, the families were asked about which
types of foods and supplements were consumed and how frequently the baby had
consumed these items since birth. The foods included: breast milk, study formula,
strained potato/vegetables, strained fruit/fruit juices, foods containing oat, wheat, barley,
or rye, foods containing corn, rice, buckwheat, or millet, foods containing pork, chicken,
turkey, lamb, or game, and foods containing fish or egg or any other foods not previously
mentioned. The supplements included vitamin D or cod liver oil, and other
vitamins/minerals.
At months one through five, the dietary form included questions about a few
additional foods not asked about at the two-week follow-up (Appendix B). These forms
included questions about consumption of regular cow’s milk/goat’s milk based formula,
Nutramigen or other hydrolyzed formula, soy-based formula, soured milk and sour milk
products (buttermilk, cultured milk, yogurt), regular cow’s milk/goat’s milk, ice cream or
cheese, foods containing beef, veal, or meat extract, sausage and other meat products
containing beef, and any others not listed above that may contain lactic acid bacteria. An
additional form was filled out at the six-month follow-up visit. This form included
questions about the same foods asked about in the previous forms. Parents were also
asked if the baby had already received the study formula and if the baby had received the
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study formula daily for at least 2 months. Parents were asked to indicate how much study
formula they still had at their home at the time of the 6-month visit, and how much
unconsumed study formula the family returned after the intervention period.

Statistical Analysis
Frequency analysis will be used to describe the demographic and anthropometric
characteristics of the total study population and stratified by maternal T1D status.
Frequency analysis will also be conducted using the variables: region, maternal
education, gender, HLA-genotype, method of delivery, birth weight and birth length,
ponderal index (birth only), body mass index (BMI), length of exclusive breastfeeding
(EBF), and maternal T1D status (MT1D). Normality statistics will be performed for the
continuous variables. Mean and median values will be calculated for weight/age, length
or height/age, and BMI/age (at birth and each subsequent time period) for the entire
cohort and by MT1D status. Ponderal Index will be used at birth rather than BMI.
Overweight and obesity status will be determined for each participant using International
Obesity Task Force (IOTF) BMI cutoff points for overweight and obesity by age and
gender. The rates (percentages) of overweight and obesity at birth and each subsequent
time period will also be calculated.
In order to evaluate the association between length of exclusive breastfeeding and
obesity by 10 years of age, a model will be created to assess the association between
length of exclusive breastfeeding and obesity rate after adjusting for covariates. Another
model will be created to evaluate the association between length of exclusive
breastfeeding and growth rate. This model will assess the association between length of
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exclusive breastfeeding and growth curves for weight, height/length, and BMI after
adjusting for covariates (gender, method of delivery, HLA-genotype, birth weight, birth
height/length, and MT1D). Weight/height data with suspected errors are corrected using
statistical algorithm prior to analysis. Race was removed from the analysis because it
was only documented in the U.S. Analysis will be divided by the following regions:
Australia, Canada, Northern Europe, Southern Europe, Central Europe I, Central Europe
II, and the United States. Type III SS model is the best because it controls for other
variables. P-values will be viewed for significance.

Summary/Conclusion
The effect of exclusive breastfeeding on the development of overweight/obesity in
children at risk for T1D is unknown. The purpose of this project was to review the
literature for research that has evaluated the association between infant diet, including
breastfeeding and complementary foods, and the development of obesity in children at
risk for T1D. After completion of the literature review, a secondary analysis proposal
was developed to investigate this relationship in a large population of children who
participated in a large international T1D prevention trial. Previous research has reported
that exclusive breastfeeding for greater than two weeks can be protective against
developing T1D, whereas early exposure to cow’s milk-based protein may increase betacell autoimmunity.14 In addition, mothers with T1D breastfeed less frequently than those
unaffected by the disease.16 The timing of introduction to complementary foods seems to
affect islet autoimmunity.17 Studies have shown an association between weight status in
children and development of T1D25,27 while breastfeeding has been found to be protective
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against overweight/obesity in children.28 The proposal has been prepared to examine the
association between length of exclusive breastfeeding and obesity risk in children at risk
for T1D for submission to the Presentations and Publications Committee of the Trial to
Reduce IDDM in the Genetically at Risk (TRIGR) study. The TRIGR study data are
ideally suited to answer this research question because there are controls for many
important confounding factors pertaining to this research question. Furthermore, the
study was conducted in an international population from birth to up to 14 years of age. A
prospective study from birth will allow evaluation of relationships between exclusive
breastfeeding and the development of overweight/obesity in children at risk for T1D
during infancy, childhood and early adolescence.
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TRIGR

Form 304

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 2
Two Week Follow-up Call

DIETARY INTERVIEW 2 weeks
Study Center

I

I

I

Registration Code

I

I

I

Date I

I
d

I
d

m

I

I

I

I

I

Local Code

I

I_ I_ I_ I _I _I _I
m m y y y
y

I

I

I__I

Randomization Code I

I

I

I

I

I__I

I

I

I
Code I

Form completed by

I

I

I

I

Print name

DIET OF THE BABY DURING THE FIRST 3 DAYS (in the hospital or at home)
e.

Has your baby received the following types of milk during the first 3 days? Mark (X) a response for
each type of milk. Also, very tiny amounts should be recorded in the column “yes.”
Don’t
Yes
No
know
Own mother’s breast milk
Banked breast milk
Study Formula
Nutramigen
Nutramigen LIPIL
Other infant formula
Brand name(s)?
National code(s) I

I

I__I , I

I

I

I

I

I__I , I

I

I

I

Other type of milk
Brand name(s)?
National code(s) I

2. What type of milk did your baby primarily receive during the first 3 days? Circle the one most
frequently used type of milk. If the baby has received two of them equally as often (e.g., its own mother’s breast
milk and the Study Formula), both numbers should be circled.
1. Own mother’s breast milk
2.

Banked breast milk

3.

Study Formula

4.

Nutramigen

5.

Nutramigen LIPIL

6. Other infant formula, brand name?
National code for the formula: I

I

I

I,I

I

I

I

I

I

I,I

I

I

7. Other type of milk, please give details
National code for the type of milk: I
8.
9.

I don’t know what type of milk my baby received primarily
None
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I

I

TRIGR

Form 304

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 2
Two Week Follow-up Call

DIETARY INTERVIEW 2 weeks
Study Center I

I

I

I

I

I Local Code I

I

_I

I

I

I

I

I

I

I Registration Code I

I

I

I

I

I

DIET OF THE BABY DURING THE FIRST 2 WEEKS
Is your baby now receiving breast milk? Please give the mother the following options, and circle the one
that is found most appropriate by her:
1. Yes

3.

2.

No, breast feeding was stopped at the age of

days

3. No, my baby has not been breast fed at all
Has your baby started to receive anything other than breast milk or water (e.g., Study Formula,
Nutramigen, juice, sugar water, strained potato/vegetables, baby cereals)?
1. Yes
2. No

4.

¾

If yes: When did your baby receive it for the first time? At the age of

5. Has your
1.
2.
¾ If yes:

¾

days

baby already received the Study Formula?
Yes
No
When did your baby receive the Study Formula for the first time? At the age of
days
How long has the baby received the Study Formula daily so far?
Days
How much Study Formula has your baby received on average per feeding during the first
two weeks?
Scoops Study Formula powder or
ml (milliliters) Study Formula liquid

If no: Skip question 6 and go to question 7

6. Is your baby now receiving the Study Formula?
1. Yes
2. No
¾

If no: When did your baby receive the Study Formula last time? At the age of

days

7. How much unconsumed Study Formula do you have at home at the time of the 2-week call?
Whole cases of formula
case(s)
Individual cans of formula
can(s)
8. Do you need more Study Formula?
1. Yes
2. No
¾

If yes: Please complete the Study Formula Distribution Form (Form 302)
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I

TRIGR

Form 304

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 2
Two Week Follow-up Call

DIETARY INTERVIEW 2 weeks
Study Center I

I

I

I

I

I Local Code I

I

_I

I

I

I

I

I

I

I Registration Code I

I

I

I

I

I

9. Which foods has your baby received since birth, and how often?
The purpose of this question is to assess how often your baby has consumed the foods listed below since
birth. Mark (X) each row of the table appropriately to indicate how often the baby has received the food(s).
If the baby has not consumed any food items in the row, mark the column “not at all”. If the food was
consumed more than 6 times per week, mark the appropriate “Times per day” box. Please do not use the
last category “Other food item” unless it is absolutely necessary. Instead, try to use the specific food
categories as much as possible for the foods consumed by the baby. There must be only one mark in
each row.

Type of food

Average frequency since birth
Times per week
Not at all

Less
than 1

1-3

Breast milk
Study Formula
Strained potato / vegetables
Strained fruit / fruit juices
Foods containing oat, wheat, barley
or rye (e.g., baby cereals, bread,
biscuits)
Foods containing corn, rice,
buckwheat or millet (e.g., baby
cereals, bread, biscuits)
Foods containing pork, chicken,
turkey, lamb, or game (e.g., strained
meat and vegetables)
Foods containing fish
(e.g., strained fish and vegetables)
Egg
Vitamin D supplementation or cod
liver oil – please list:
Other vitamins/minerals, please list:
Other food item – please list:
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Times per day
4-6

1-2

3-4

5 or more

I

TRIGR

Form 304

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 2
Two Week Follow-up Call

DIETARY INTERVIEW 2 weeks
Study Center I

10.

I

I

I

I

I Local Code I

I

_I

I

I

I

I

I

I

I Registration Code I

I

I

I

I

I

Has your baby received any foods that are not allowed during the dietary intervention period?

Foods not allowed during the dietary intervention period are mentioned in the table below. In case the baby
has received any of those since birth, mark (X) each row of the table appropriately to indicate how often
the baby has received the food(s). If the baby has not consumed any food items in the row, mark the
column “not at all”. If the food was consumed more than 6 times per week, mark the appropriate “Times per
day” box. There must be only one mark in each row.

Type of food

Average frequency since birth
Times per week
Times per day
Not at all

Less than
1

1-3

4-6

1-2

Regular cow’s / goat’s
milk-based formula, as
such or used in cooking
Brand name(s)?

National code(s) I

I

I

I , I__I

Nutramigen* or other
hydrolyzed formula**
Brand name(s)?

National code(s) I

I

I

I

National code(s) I

I

I

I

I

I

Soy-based formula**
Brand name(s)?

Soured milk and sour milk
products
(e.g., buttermilk, cultured milk,
yogurt)
Regular cow’s / goat’s milk, ice
cream
or cheese, as such, in
commercial baby foods, or
when used in cooking (e.g.,
baby foods)
Foods containing beef,
veal or meat extract (e.g.,
strained beef and
vegetables)
Sausage and other meat
products containing beef
Other – please list (e.g., milk
containing lactic acid bacteria
supplements)
* Nutramigen can be given in the delivery hospital if the Study Formula is not available
** Other infant formulas than the Study Formula are not allowed during the dietary intervention period
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3-4

5 or more

I

Appendix B

33

TRIGR

Form 305

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 3
One-Month Follow-up Call

DIETARY INTERVIEW 1 month
Study Center

I

I

I

Registration Code

I

I

I

Date I

I
d

I
d

m

I

I

I

I

I

Local Code

I

I_ I_ I_ I _I _I _I
m m y y y
y

I

I

Randomization Code I

I__I

I

I

I

I

I__I

I

I

I

I

I
Code I

Form completed by

I

I

I

Print name

Is your baby now receiving breast milk? Please give the mother the following options, and circle the one
that is found most appropriate by her:
1. Yes

1.

2.

No, breast feeding was stopped at the age of

days

3. No, my baby has not been breast fed at all
Has your baby started to receive anything other than breast milk or water (e.g., Study Formula,
Nutramigen, juice, strained potato/vegetables, baby cereals)?
1. Yes
2. No

2.

¾

If yes: When did your baby receive it for the first time? At the age of

3. Has your
1.
2.
¾ If yes:

¾

days

baby already received the Study Formula?
Yes
No
When did your baby receive the Study Formula for the first time? At the age of
days
How long has the baby received the Study Formula daily so far?
days
How much Study Formula has your baby received on average per feeding during the
preceding two weeks?
scoops Study Formula powder or
ml (milliliters) Study Formula liquid

If no: Skip question 4 and go to question 5

4. Is your baby now receiving the Study Formula?
1. Yes
2. No
¾

If no: When did your baby receive the Study Formula last time? At the age of

days

5. How much unconsumed Study Formula do you have at home at the time of the 1-month call?
Whole cases of formula
case(s)
Individual cans of formula
can(s)
6. Do you need more Study Formula?
1. Yes
2. No
¾

If yes: Please complete the Study Formula Distribution Form (Form 302)
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Form 305

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 3
One-Month Follow-up Call

DIETARY INTERVIEW 1 month
Study Center I

I

I

I

I

I Local Code I

I

_I

I

I

I

I

I

I

I Registration Code I

I

I

I

I

I

7. Which foods has your baby received since the 2-week call, and how often?
The purpose of this question is to assess how often your baby has consumed the foods listed below since
the 2-week call. Mark (X) each row of the table appropriately to indicate how often the baby has received
the food(s). If the baby has not consumed any food items in the row, mark the column “not at all”. If the
food was consumed more than 6 times per week, mark the appropriate “Times per day” box. Please do not
use the last category, “other food item”, unless it is absolutely necessary. Instead, try to use the specific
food categories as much as possible to describe the foods consumed by the baby. There must be only
one mark in each row.

Type of food

Average frequency since the 2-week call
Times per week
Not at all

Less
than 1

1-3

Breast milk
Study Formula
Strained potato / vegetables
Strained fruit / fruit juices
Foods containing oat, wheat, barley
or rye (e.g., baby cereals, bread,
biscuits)
Foods containing corn, rice,
buckwheat or millet (e.g., baby
cereals, bread, biscuits)
Foods containing pork, chicken,
turkey, lamb, or game (e.g., strained
meat and vegetables)
Foods containing fish
(e.g., strained fish and vegetables)
Egg
Vitamin D supplementation or cod
liver oil – please list:
Other vitamins/minerals, please list:
Other food item – please list:
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Times per day
4-6

1-2

3-4

5 or more

I

TRIGR

Form 305

Nutritional Prevention of Type 1 Diabetes

North America Region

Contact no. 3
One-Month Follow-up Call

DIETARY INTERVIEW 1 month
Study Center I

8.

I

I

I

I

I Local Code I

I

_I

I

I

I

I

I

I

I Registration Code I

I

I

I

I

I

Has your baby received any foods since the 2-week call that are not allowed during the dietary
intervention period?
Foods not allowed during the dietary intervention period are mentioned in the table below. In case the baby
has received any of those since the 2-week call, mark (X) each row of the table appropriately to indicate
how often the baby has received the food(s). If the baby has not consumed any food items in the row, mark
the column “not at all”. If the food was consumed more than 6 times per week, mark the appropriate “Times
per day” box. There must be only one mark in each row.

Type of food

Average frequency since the 2-week call
Times per week
Times per day
Not at all

Less
than 1

1-3

4-6

1-2

Regular cow’s / goat’s
milk-based formula, as
such or used in cooking
Brand name(s)?

National code(s) I

I

I

I

Brand name(s)?

National code(s) I

I

I

I

Soy-based formula*
Brand name(s)?

National code(s) I

I

I

I

Nutramigen or other
hydrolyzed formula*

Soured milk and sour milk
products (e.g., buttermilk,
cultured milk, yogurt)
Regular cow’s / goat’s milk,
ice cream or cheese, as
such, in commercial baby
foods, or when used in
cooking (e.g., baby foods)
Foods containing beef,
veal or meat extract (e.g.,
strained beef and
vegetables)
Sausage and other meat
products containing beef
Other – please list
(e.g., milk containing
lactic acid bacteria
supplements)
* Other infant formulas than the Study Formula are not allowed during the dietary intervention period
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3-4

5 or more

I

